The first clinical trials are slated to begin in the U.S. and Europe while others are stalled.
This drug removed all traces of cancer in one UK man.
The gene-editing technology’s cancer treatment safety test could start later this year
The immune system’s T cells, often evaded by tumors, might now resume the attack.
The robo-doc will match patients to experimental treatments